# Ruige Pharmaceutical

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ruige-pharmaceutical

- Industry: Pharmaceuticals
- Headquarters: Shanghai, China
- Website: www.regor.com
- Total disclosed funding: $90M
- Latest round: Series B (Feb 19, 2021)
- Investors on record: 5

## About

Established in 2018 and based in Shanghai, China, Ruige Pharmaceutical is a medical company that focuses on the research and development of drugs in the field of tumors, autoimmunity and metabolism.

The company engages in the research and development of drugs. It has a CARD technology platform that combines structural biology, computational chemistry, medicinal chemistry and biology. The CARD technology platform provides drug research and development services.

## Funding rounds

- Series B, Feb 19, 2021, $90M — Lilly Asia Ventures, Vertex Ventures China, Loyal Valley Capital, TF Capital, Lanting Capital

## Investors

- Lilly Asia Ventures (https://capitalatlas.ai/funds/lilly-asia-ventures) — Series B
- Vertex Ventures China (https://capitalatlas.ai/funds/vertex-ventures-china) — Series B
- Loyal Valley Capital (https://capitalatlas.ai/funds/loyal-valley-capital) — Series B
- TF Capital — Series B
- Lanting Capital (https://capitalatlas.ai/funds/lanting-capital) — Series B